Learn, Analyse & Invest
only with
only with
+91
Download Orca
0.00
- With a market cap of N/A.
| EX-Date | Purpose |
|---|---|
| 12 05 2021 | Inter alia, to consider and evaluate proposals for raising of funds in one or more tranches by way of issue of Equity Shares or Securities/ Warrants convertible into Equity shares of the Company, through permissible modes including by way of Preferential Issue, subject to the receipt of necessary approvals. |
| 17 05 2021 | Audited Results |
| 26 07 2021 | Quarterly Results |
| 01 09 2021 | SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/09/2021 ,inter alia, to consider and approve / evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals. |
| 01 11 2021 | Quarterly Results |
| 04 02 2022 | Quarterly Results |
| 17 05 2022 | Audited Results |
| 08 08 2022 | Quarterly Results & Inter alia, to consider and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals.531433 Sungold Capital Ltd. 09/08/2022 Quarterly Results |
| 07 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 22 05 2023 | Audited Results |
| 22 05 2023 | Audited Results Inter alia, to consider and approve and evaluate various options or proposals for raising funds through any of the permissible modes, subject to the receipt of necessary approvals |
| 07 08 2023 | Quarterly Results |
| 06 11 2023 | Quarterly Results |
| 05 02 2024 | Quarterly Results |
| 04 11 2024 | Quarterly Results |
| 10 02 2025 | Quarterly Results |
| 19 05 2025 | Quarterly Results & Audited Results |
News
No News data available
